XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1

EQUITY-BASED COMPENSATION PLAN (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Range of Exercise Prices and Weighted Average Remaining Contractual Life

The activity in outstanding options for 2023, 2022, and 2021 is set forth below:

			Year Ended December 31,
			2023												2022												2021
			Number Of Options						Weighted Average Exercise Price						Number Of Options						Weighted Average Exercise Price						Number Of Options						Weighted Average Exercise Price
Beginning of year			234,950						$	16.38					338,494						$	15.76					481,444						$	15.10
Options exercised			(218,350)						16.34						(103,544)						14.34						(140,850)						13.51
Options forfeited			—						—						—						—						(2,100)						16.55
End of year			16,600						$	16.92					234,950						$	16.38					338,494						$	15.76

The following table summarizes the range of exercise prices and the weighted average remaining contractual life of the options outstanding at December 31, 2023:

			Outstanding																		Exercisable
Range of Exercise Prices			Number of Options						Weighted Average Exercise Price						Weighted Average Contract Life Remaining (Years)						Number of Options						Weighted Average Exercise Price
14.09 to 16.90			6,400						16.10						0.2						6,400						16.10
16.91 to 19.71			10,200						17.44						1.2						10,200						17.44
			16,600						$	16.92					0.8						16,600						$	16.92
Aggregate Intrinsic Value			$	341,240																	$	341,240

Schedule of Restricted Stock Unit Activity under the Omnibus Plan

The following table summarizes the activity in restricted units under the Omnibus Plan for 2023, 2022 and 2021:

			Year Ended December 31,
			2023												2022												2021
			Restricted Units						Weighted Average Grant Date Fair Value						Restricted Units						Weighted Average Grant Date Fair Value						Restricted Units						Weighted Average Grant Date Fair Value
Beginning of year			408,832						$	22.27					511,740						$	19.35					529,770						$	15.58
Restricted units granted			204,048						27.84						178,281						27.89						205,440						18.76
Restricted units lapsed			(181,692)						20.85						(277,866)						17.08						(218,188)						13.85
Restricted units forfeited			(20,191)						25.18						(3,323)						22.89						(5,282)						19.38
End of year			410,997						$	25.43					408,832						$	22.27					511,740						$	19.35

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration